Granule and preparation method thereof
A pharmaceutical granule whose shape is spherical or sphere-like shape with a bulk density of 0.6-1.3 g/ml and a dissolution time of 0.5-5 minutes, which is prepared as follows: mother granules are filled into a fluidized-bed as bed charge; active pharmaceutical ingredients are prepared into a suspension or solution whose viscosity is adjusted to 6.0-9.8 Mpa·S with viscosity adjusting agent; then it is sprayed onto surface of said mother granule to obtain final granule.
1. A method for preparing a pharmaceutical granule comprising a mother granule and shell layer, the preparation method comprising:
(1) producing mother granules having a diameter of from 200 μm to 750 μm, wherein the mother granules comprise a pharmaceutically acceptable carrier and/or an active pharmaceutical ingredient, selected from the group consisting of Yangxue Qingnao extractum, XiaoKeQing extractum, FufangDanshen extractum, Coptis chinesis Franch extractum and Radix Bupleuri Chinesis extractum, and are prepared by a process comprising:
(i) grinding and sieving a dry powder comprising a pharmaceutically acceptable carrier and/or an active pharmaceutical ingredient to obtain a particulate material with particle diameters small enough to pass through a 200 mesh sieve;
(ii) filling a first portion of the particulate material into a side-spraying or bottom-spraying spot of a fluidized bed, and spraying said first portion of the particulate material into the fluidized bed, wherein the temperature in the fluidized bed is from 40-75° C.;
(iii) mixing a second portion of the particulate material with water to form a slurry, and spraying the slurry into the fluidized bed;
(iv) screening the contents of the fluidized bed to obtain particles with a diameter of from 180 μm to 250 μm for use as mother cores;
(iv) putting the mother cores into a side-spraying or bottom-spraying spot of a fluidized bed;
(v) dusting the mother cores with a third portion of the particulate material, while simultaneously spraying the mother cores with the slurry of step (iii); and
(vi) screening the contents of the fluidized bed to obtain mother granules having a particle diameter of from 200 μm to 750 μm;
(2) filling the mother granules into a fluidized bed;
(3) insufflating a gas flow into the fluidized bed;
(4) preparing a viscous suspension comprising a pharmaceutically active ingredient selected from the group consisting of Yangxue Qingnao extractum, XiaoKeQing extractum, FufangDanshen extractum, Coptis chinensis Franch extractum and Radix Bupleuri Chinensis extractum, wherein the suspension has a viscosity of from 6.0 to 9.8 Mpa·s and is prepared by a process comprising:
(i) diluting the active pharmaceutical ingredient with water or a pharmaceutically acceptable organic solvent, thereby producing a diluted pharmaceutical mixture in the form of a suspension having a solid content of from 15-40 wt. %; and
(ii) adjusting the viscosity of the diluted pharmaceutical mixture with a viscosity adjusting agent selected from the group consisting of microcrystalline cellulose, micro-powder silica gel, polyethylene glycol, talc powder, chitosan, polyvidon, hydroxypropyl methylcellulose, and combinations thereof;
(5) spraying the mother granules with the viscous suspension of step (4) to create a shell layer, thereby producing the pharmaceutical granule; wherein the resulting pharmaceutical granule is spherical or sphere-like in shape, and has a bulk density of from 0.6 to 1.3 g/mL and a dissolution time of 0.5-5 minutes, and wherein the pharmaceutically acceptable carrier comprises from 10-60 wt. % relative to the total weight of the granule.
2. The method for preparing a pharmaceutical granule according to claim 1 , wherein the temperature of the fluidized bed is 40-55° C.
3. The method for preparing a pharmaceutical granule according to claim 1 , wherein the temperature of the fluidized bed is 45° C.